Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
Ayez N, van der Stok EP, de Wilt H, Radema SA, van Hillegersberg R, Roumen RM, Vreugdenhil G, Tanis PJ, Punt CJ, Dejong CH, Jansen RL, Verheul HM, de Jong KP, Hospers GA, Klaase JM, Legdeur MC, van Meerten E, Eskens FA, van der Meer N, van der Holt B, Verhoef C, Grünhagen DJ.
Ayez N, et al. Among authors: van meerten e, van hillegersberg r, van der meer n, van der stok ep, van der holt b.
BMC Cancer. 2015 Mar 26;15:180. doi: 10.1186/s12885-015-1199-8.
BMC Cancer. 2015.
PMID: 25884448
Free PMC article.
Clinical Trial.